Pfizer has resolved a lawsuit filed by a conservative group that alleged its diversity fellowship program unlawfully discriminated against white and Asian-American applicants. The program was established to increase the representation of Black, Latino, and Native American individuals in leadership positions within the company.
The resolution of this legal challenge removes a potential source of litigation and reputational risk for Pfizer. The terms of the resolution were not disclosed.
This outcome allows Pfizer to move forward from the legal dispute concerning its efforts to boost diversity within its leadership pipeline.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.